Year: 2026
-
Imaging Agent May Improve Diagnoses for Rare Heart Disease
A PET/CT radiotracer demonstrated high sensitivity and specificity for detecting cardiac amyloidosis and could provide diagnostic clarity when standard imaging tests do not provide definitive results, according to a recent clinical trial published in JAMA.
-
RNA Therapy May Help Preserve Muscle During GLP-1 Weight Loss
A new Northwestern University study offers a potential solution to muscle loss during GLP-1 therapy: an experimental RNA therapy that induces the body to burn calories, enhancing the benefits of the weight-loss treatment.
-
Genetic Toolkit May Improve Study of Gut Bacteria’s Role in Disease
A novel genetic toolkit may improve the study of how Clostridia bacteria in the gut contribute to disease and reveal new molecular mechanisms that may serve as effective therapeutic targets, as detailed in a recent study published in Nature Biotechnology.
-
Experimental Drug Shows Potential for Hard-to-Treat Heart Disease
An experimental drug has been shown to improve symptoms, exercise capacity and heart failure status in patients with an inherited heart disease, according to a pair of newly published studies.
-
Investigating the Role of Lymphatic Vessels in Heart Growth and Repair
A Northwestern Medicine study has uncovered a previously unknown signaling system that helps regulate heart growth during development, according to the study published in the journal Genes and Development.
-
Research Day 2026 Recognizes Scientific Excellence and Collaboration
Feinberg students, staff, trainees and faculty celebrated scientific discoveries and collaboration and presented their research posters and abstracts at the 20th annual Lewis Landsberg Research Day on Thursday, Sept. 10.
-
Combination Therapy May Improve Immune Response Against Advanced Prostate Cancer
Combining two therapies may improve immune response in a subgroup of patients with metastatic castration-resistant prostate cancer who responded poorly to initial treatment, according to a Northwestern Medicine study published in The Journal of Clinical Investigation.
-
Surgeon-Scientist Honored with 2026 Tripartite Prize
Daniela Ladner, MD, MPH, the John Benjamin Murphy Professor of Surgery and vice chair of research and innovation in the Department of Surgery, has been named the winner of the 2026 Tripartite Legacy Faculty Prize in Translational Science and Education.
-
Understanding the Link Between Genetic Risk and Brain Communication Disorders
A new Northwestern Medicine study suggests a major psychiatric risk gene remains important well into adulthood and may influence brain communication, according to a study published in the Proceedings of the National Academy of Sciences.
-
Identifying Patients at Lower Risk for Kidney Transplant Rejection
A new risk stratification model developed by Northwestern Medicine scientists may help better identify patients who have a lower risk of kidney transplant rejection, which can inform more personalized treatment and care strategies that present fewer adverse side effects, as detailed in a recent study published in Nature Communications.
